Hangzhou Endonom Medtech Co., Ltd.
Clinical trials sponsored by Hangzhou Endonom Medtech Co., Ltd., explained in plain language.
-
New plug could boost aortic repair success
Disease control Recruiting nowThis study tests whether adding a special plug (WeFlow-EndoSeal™) to standard stent-graft repair improves outcomes for people with a tear in the aorta's inner layer (type B aortic dissection). About 256 adults with subacute or chronic dissection will be randomly assigned to get t…
Phase: NA • Sponsor: Hangzhou Endonom Medtech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New stent aims to fix deadly aortic aneurysms without open surgery
Disease control Recruiting nowThis study tests a new device called the WeFlow-Tribranch stent graft system to repair aneurysms or ulcers in the aortic arch. About 90 people aged 18 to 80 with these conditions will receive the stent through a minimally invasive procedure. The main goal is to see if the device …
Phase: NA • Sponsor: Hangzhou Endonom Medtech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC